News & Events about Cardiff Oncology Inc.
Cardiff Oncology to Present at Upcoming Investor Conferences Cardiff Oncology to Present at Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 21, 2022 SAN DIEGO, Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1...
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028 Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028 PR Newswire Palm Beach, Fla., Oct. 12, 2022 FinancialNewsMedia.com News Commentary Palm Beach, Fla., Oct. 12, 2022...
Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022 Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress...
Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022 Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022 PR Newswire SAN DIEGO, Aug. 29, 2022 Event to feature...
Cardiff Oncology to Present at the William Blair Biotech Focus Conference 2022 Cardiff Oncology to Present at the William Blair Biotech Focus Conference 2022 PR Newswire SAN DIEGO, July 5, 2022 SAN DIEGO, July 5, 2022 /PRNewswire/ --Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage...